YANCOPOULOS GEORGE sold REGN
May 15, 2024 · Form 4 insider transaction
YANCOPOULOS GEORGE sold 53 shares of Regeneron Pharmaceuticals, Inc. at $984.02 per share, a transaction worth $52.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
53
Price
$984.02
Total value
$52.2K
InsiderYANCOPOULOS GEORGE
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 15, 2024
Filing dateMay 17, 2024
Shares owned after838,147
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.